Emerging Strategies of Cancer Therapy Based on Ferroptosis

Ferroptosis, a new form of regulated cell death that is iron‐ and reactive oxygen species dependent, has attracted much attention in the research communities of biochemistry, oncology, and especially material sciences. Since the first demonstration in 2012, a series of strategies have been developed to induce ferroptosis of cancer cells, including the use of nanomaterials, clinical drugs, experimental compounds, and genes. A plethora of research work has outlined the blueprint of ferroptosis as a new option for cancer therapy. However, the published ferroptosis‐related reviews have mainly focused on the mechanisms and pathways of ferroptosis, which motivated this contribution to bridge the gap between biological significance and material design. Therefore, it is timely to summarize the previous efforts on the emerging strategies for inducing ferroptosis and shed light on future directions for using such a tool to fight against cancer. Here, the current strategies of cancer therapy based on ferroptosis will be elaborated, the design considerations and the advantages and limitations are highlighted, and finally a future perspective on this emerging field is given.

[1]  M. Conrad,et al.  Iron and ferroptosis: A still ill‐defined liaison , 2017, IUBMB life.

[2]  Guofeng Zhang,et al.  Activatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer Therapy. , 2017, Angewandte Chemie.

[3]  C. Culmsee,et al.  BID links ferroptosis to mitochondrial cell death pathways , 2017, Redox biology.

[4]  L. Schöckel,et al.  Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells , 2017, Cell Death and Disease.

[5]  J. Bertin,et al.  Neuronal Death After Hemorrhagic Stroke In Vitro and In Vivo Shares Features of Ferroptosis and Necroptosis , 2017, Stroke.

[6]  B. Stockwell,et al.  Heat stress induces ferroptosis-like cell death in plants , 2017, The Journal of cell biology.

[7]  Xinyang Zhang,et al.  Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species. , 2017, Nano letters.

[8]  Xiuwen Zheng,et al.  pH-Responsive, Self-Sacrificial Nanotheranostic Agent for Potential In Vivo and In Vitro Dual Modal MRI/CT Imaging, Real-Time, and In Situ Monitoring of Cancer Therapy. , 2017, Bioconjugate chemistry.

[9]  Xian‐Zheng Zhang,et al.  Switching Apoptosis to Ferroptosis: Metal-Organic Network for High-Efficiency Anticancer Therapy. , 2017, Nano letters.

[10]  J. Roh,et al.  Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis , 2016, Redox biology.

[11]  Gang Chen,et al.  Ferroptosis, a new form of cell death, and its relationships with tumourous diseases , 2016, Journal of cellular and molecular medicine.

[12]  K. D'Herde,et al.  Ferroptosis: Oxidized PEs trigger death. , 2017, Nature chemical biology.

[13]  A. Walch,et al.  ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. , 2017, Nature chemical biology.

[14]  Morteza Mahmoudi,et al.  Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. , 2016, Nature nanotechnology.

[15]  M. Murphy.  Ironing out how p53 regulates ferroptosis , 2016, Proceedings of the National Academy of Sciences.

[16]  P. Zou,et al.  Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells. , 2016, Cancer letters.

[17]  W. Gu,et al.  Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression. , 2016, Cell reports.

[18]  D. Tang,et al.  Identification of ACSL4 as a biomarker and contributor of ferroptosis. , 2016, Biochemical and biophysical research communications.

[19]  D. Tang,et al.  CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation. , 2016, Biochemical and biophysical research communications.

[20]  B. Stockwell,et al.  A Mitochondrial-Targeted Nitroxide Is a Potent Inhibitor of Ferroptosis , 2016, ACS central science.

[21]  Q. Pan,et al.  Ferroptosis is an autophagic cell death process , 2016, Cell Research.

[22]  M. Gonen,et al.  Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth , 2016, Nature nanotechnology.

[23]  D. Tang,et al.  Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis , 2016, Hepatology.

[24]  Aiguo Wu,et al.  Improved SERS-Active Nanoparticles with Various Shapes for CTC Detection without Enrichment Process with Supersensitivity and High Specificity. , 2016, ACS applied materials & interfaces.

[25]  Y. C. Long,et al.  Crosstalk between cystine and glutathione is critical for the regulation of amino acid signaling pathways and ferroptosis , 2016, Scientific Reports.

[26]  C. Fan,et al.  Silica Nanoparticles Target a Wnt Signal Transducer for Degradation and Impair Embryonic Development in Zebrafish , 2016, Theranostics.

[27]  Yongqiang Chen,et al.  Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells , 2016, Cell Death and Disease.

[28]  P. Vandenabeele,et al.  Regulated necrosis: disease relevance and therapeutic opportunities , 2016, Nature reviews. Drug discovery.

[29]  W. Ran,et al.  Recent Progress in Light-Triggered Nanotheranostics for Cancer Treatment , 2016, Theranostics.

[30]  J. Egido,et al.  CD163-Macrophages Are Involved in Rhabdomyolysis-Induced Kidney Injury and May Be Detected by MRI with Targeted Gold-Coated Iron Oxide Nanoparticles , 2016, Theranostics.

[31]  M. Rauh,et al.  Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema , 2016, Oncotarget.

[32]  W. Carroll,et al.  Five-Membered Ring Peroxide Selectively Initiates Ferroptosis in Cancer Cells. , 2016, ACS chemical biology.

[33]  D. Tang,et al.  Ferroptosis: process and function , 2016, Cell Death and Differentiation.

[34]  Heliang Yao,et al.  Synthesis of Iron Nanometallic Glasses and Their Application in Cancer Therapy by a Localized Fenton Reaction. , 2016, Angewandte Chemie.

[35]  Chen-Sheng Yeh,et al.  Ultrasound-Induced Reactive Oxygen Species Mediated Therapy and Imaging Using a Fenton Reaction Activable Polymersome. , 2016, ACS nano.

[36]  D. Tang,et al.  Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells , 2016, Hepatology.

[37]  Feng Cao,et al.  In vivo MR and Fluorescence Dual-modality Imaging of Atherosclerosis Characteristics in Mice Using Profilin-1 Targeted Magnetic Nanoparticles , 2016, Theranostics.

[38]  M. Tan,et al.  A novel Trojan-horse targeting strategy to reduce the non-specific uptake of nanocarriers by non-cancerous cells. , 2015, Biomaterials.

[39]  Andrea Glasauer,et al.  Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth , 2015, Cancer & metabolism.

[40]  T. Efferth,et al.  Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[41]  Shang‐Hsiu Hu,et al.  Targeted Mesoporous Iron Oxide Nanoparticles-Encapsulated Perfluorohexane and a Hydrophobic Drug for Deep Tumor Penetration and Therapy , 2015, Theranostics.

[42]  L. Galluzzi,et al.  Ferroptosis in p53-dependent oncosuppression and organismal homeostasis , 2015, Cell Death and Differentiation.

[43]  Minghui Gao,et al.  Glutaminolysis and Transferrin Regulate Ferroptosis. , 2015, Molecular cell.

[44]  Nils Eling,et al.  Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells , 2015, Oncoscience.

[45]  G. Bornkamm,et al.  T cell lipid peroxidation induces ferroptosis and prevents immunity to infection , 2015, The Journal of experimental medicine.

[46]  W. Gu,et al.  Ferroptosis as a p53-mediated activity during tumour suppression , 2015, Nature.

[47]  Haichao Wang,et al.  HSPB1 as a Novel Regulator of Ferroptotic Cancer Cell Death , 2015, Oncogene.

[48]  Jos L. Campbell,et al.  Theranostic Mesoporous Silica Nanoparticles Biodegrade after Pro-Survival Drug Delivery and Ultrasound/Magnetic Resonance Imaging of Stem Cells , 2015, Theranostics.

[49]  B. Chauffert,et al.  The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells. , 2015, Cancer letters.

[50]  A. Walch,et al.  Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice , 2014, Nature Cell Biology.

[51]  B. Chauffert,et al.  Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors. , 2014, Anticancer research.

[52]  Tamer Refaat,et al.  Passive targeting of nanoparticles to cancer: A comprehensive review of the literature. , 2014, Molecular and clinical oncology.

[53]  Matthew E. Welsch,et al.  Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis , 2014, eLife.

[54]  Jianliang Shen,et al.  Cyclodextrin and Polyethylenimine Functionalized Mesoporous Silica Nanoparticles for Delivery of siRNA Cancer Therapeutics , 2014, Theranostics.

[55]  Matthew E. Welsch,et al.  Regulation of Ferroptotic Cancer Cell Death by GPX4 , 2014, Cell.

[56]  W. Gu,et al.  To be, or not to be: functional dilemma of p53 metabolic regulation , 2014, Current opinion in oncology.

[57]  B. Stockwell,et al.  The role of iron and reactive oxygen species in cell death. , 2014, Nature Chemical Biology.

[58]  P. Padmanabhan,et al.  Multifunctional Iron Oxide Nanoparticles for Diagnostics, Therapy and Macromolecule Delivery , 2013, Theranostics.

[59]  T. Mak,et al.  Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.

[60]  Xing-jie Liang,et al.  Biocompatible composite nanoparticles with large longitudinal relaxivity for targeted imaging and early diagnosis of cancer. , 2013, Journal of materials chemistry. B.

[61]  A. Strasser,et al.  p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa. , 2013, Cell reports.

[62]  P. Kalivas,et al.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. , 2013, Antioxidants & redox signaling.

[63]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[64]  J. Long,et al.  Introduction to metal-organic frameworks. , 2012, Chemical reviews.

[65]  Wei Wei,et al.  A galactosamine-mediated drug delivery carrier for targeted liver cancer therapy. , 2011, Pharmacological research.

[66]  Cord Sunderkötter,et al.  An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. , 2011, The Journal of clinical investigation.

[67]  N. Plesnila,et al.  Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. , 2008, Cell metabolism.

[68]  P. Gout,et al.  The x  c− cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases , 2008, Journal of cellular physiology.

[69]  B. Stockwell,et al.  Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. , 2008, Chemistry & biology.

[70]  B. Stockwell,et al.  RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels , 2007, Nature.

[71]  Henry Jay Forman,et al.  Redox signaling , 2004, Molecular and Cellular Biochemistry.

[72]  William C Hahn,et al.  Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. , 2003, Cancer cell.

[73]  H. Dunford,et al.  Oxidations of iron(II)/(III) by hydrogen peroxide: from aquo to enzyme , 2002 .

[74]  P. Maher,et al.  Oxytosis: A novel form of programmed cell death. , 2001, Current topics in medicinal chemistry.

[75]  P. Duwez,et al.  Non-crystalline Structure in Solidified Gold–Silicon Alloys , 1960, Nature.

[76]  H. Fenton,et al.  LXXIII.—Oxidation of tartaric acid in presence of iron , 1894 .